FIELD: ophthalmology.
SUBSTANCE: invention is intended to assess the quality of life (QoL) in unilateral cataracts after phacoemulsification and IOL implantation. The patient's visual acuity (BCVA) is determined and the "Assessment of the quality of life in patients with cataracts" ("ФЭК-22") questionnaire is used. The total number of QoL points is determined. With a score of less than 157 points and BCVA of 0.4 or less relative units, the quality of life is assessed as low. With a total score of QoL as 158–191 points and BCVA as 0.5–0.8 relative units, the quality of life is assessed as average. When the value of the sum of QoL points is 192 points or more and BCVA is 0.9–1.0 relative units, the quality of life is assessed as high.
EFFECT: method provides an assessment of the quality of life after “ФЭК” to select an adequate tactics for managing patients through the use of a complex of the most significant indicators.
1 cl, 4 tbl, 9 ex
